This data is derived from company filings and other reputable sources. It has not been generated by AI. It is intended to help verify and validate the AI analysis here. We believe this data to be accurate but we cannot guarentee that it is error free and it should not be relied upon for financial decisions.
| Name | Recursion Pharmaceuticals Inc |
| Asset Type | Common Stock |
| Industry | Biological Products, (No Disgnostic Substances) |
| Market Capitalization | 2552643000 |
| Pe Ratio | None |
| Peg Ratio | None |
| Book Value | 2.608 |
| Dividend Yield | None |
| Eps | -1.69 |
| Analyst Target Price | 9 |
| Analyst Rating Strong Buy | 1 |
| Analyst Rating Buy | 1 |
| Analyst Rating Hold | 6 |
| Analyst Rating Sell | 0 |
| Analyst Rating Strong Sell | 0 |
| Trailing Pe | – |
| Forward Pe | – |
| Beta | 0.845 |
| Price To Sales Ratio | 43.38 |
| Price To Book Ratio | 2.467 |
Quarterly Financial Statements
Ratios
| 0 | 1 | 2 | 3 | 4 | |
|---|---|---|---|---|---|
| Fiscal Date Ending | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| Reported Currency | USD | USD | USD | USD | USD |
| Free Cash Flow | -63.79M | -86.40M | -108.95M | -76.49M | -73.75M |
| Current Ratio | 4.35 | 6.07 | 4.65 | 4.70 | 4.36 |
| Quick Ratio | N/A | N/A | N/A | N/A | 4.34 |
| Debt to Equity Ratio | 0.38 | 0.33 | 0.39 | 0.41 | 0.44 |
| Interest Coverage Ratio | -177.86 | -255.19 | -4.6K | -3.7K | -3.7K |
| Net Profit Margin | -3.67 | -6.77 | -6.63 | -8.56 | -8.85 |
| Gross Profit Margin | -1.12 | -2.18 | -2.35 | -3.14 | -3.14 |
| Return on Assets (ROA) | -0.13 | -0.13 | -0.16 | -0.14 | -0.15 |
| Return on Equity (ROE) | -0.18 | -0.17 | -0.23 | -0.20 | -0.21 |
| COGS Ratio | 2.12 | 3.18 | 3.35 | 4.14 | 4.14 |
| Inventory Turnover | N/A | N/A | N/A | N/A | 19.27 |
| Receivables Turnover | 11.57 | 5.71 | 5.30 | 3.51 | 3.32 |
| Asset Turnover | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 |
| ROIC | -0.33 | -0.33 | -0.35 | -0.35 | -0.38 |
Income Statement
| 0 | 1 | 2 | 3 | 4 | |
|---|---|---|---|---|---|
| Fiscal Date Ending | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| Reported Currency | USD | USD | USD | USD | USD |
| Gross Profit | -29.31M | -31.50M | -32.31M | -34.07M | -32.97M |
| Total Revenue | 26.08M | 14.42M | 13.77M | 10.87M | 10.51M |
| Cost Of Revenue | 55.40M | 45.92M | 46.08M | 44.94M | 43.48M |
| Costof Goods And Services Sold | 12.08M | 9.20M | 11.17M | 9.88M | 10.88M |
| Operating Income | -98.35M | -100.54M | -96.34M | -98.93M | -99.55M |
| Selling General And Administrative | 37.76M | 31.83M | 31.41M | 30.46M | 29.20M |
| Research And Development | 74.60M | 73.93M | 67.56M | 69.48M | 70.01M |
| Operating Expenses | 117.92M | 110.65M | 102.48M | 104.54M | 102.61M |
| Investment Income Net | None | None | None | None | None |
| Net Interest Income | 3.27M | 2.87M | -20.0K | -26.0K | -25.0K |
| Interest Income | 3.83M | 3.27M | 4.05M | 4.52M | 4.98M |
| Interest Expense | 553.0K | 394.0K | 20.0K | 26.0K | 25.0K |
| Non Interest Income | 26.08M | 14.42M | 13.79M | 10.89M | 10.53M |
| Other Non Operating Income | None | None | None | None | None |
| Depreciation | 4.00M | 4.10M | 4.00M | 4.20M | 4.20M |
| Depreciation And Amortization | 5.56M | 4.88M | 3.40M | 3.40M | 3.40M |
| Income Before Tax | -95.67M | -98.06M | -92.15M | -97.06M | -93.02M |
| Income Tax Expense | 167.0K | -523.0K | -779.0K | -4.06M | 0.00 |
| Interest And Debt Expense | 553.0K | 394.0K | 20.0K | 26.0K | 25.0K |
| Net Income From Continuing Operations | -95.84M | -97.54M | -91.37M | -93.00M | -93.02M |
| Comprehensive Income Net Of Tax | -95.84M | -97.54M | -91.37M | -93.00M | -93.02M |
| Ebit | -98.35M | -100.54M | -92.13M | -97.03M | -92.99M |
| Ebitda | -92.79M | -95.66M | -88.73M | -93.63M | -89.59M |
| Net Income | -95.84M | -97.54M | -91.37M | -93.00M | -93.02M |
Balance Sheet
| 0 | 1 | 2 | 3 | 4 | |
|---|---|---|---|---|---|
| Fiscal Date Ending | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| Reported Currency | USD | USD | USD | USD | USD |
| Total Assets | 726.50M | 775.86M | 557.85M | 653.70M | 630.83M |
| Total Current Assets | 474.17M | 522.38M | 343.62M | 438.14M | 410.52M |
| Cash And Cash Equivalents At Carrying Value | 427.65M | 474.34M | 296.33M | 391.56M | 387.32M |
| Cash And Short Term Investments | 427.65M | 474.34M | 296.33M | 391.56M | 387.32M |
| Inventory | None | None | None | None | 2.26M |
| Current Net Receivables | 2.25M | 2.53M | 2.60M | 3.09M | 3.16M |
| Total Non Current Assets | 252.33M | 253.49M | 214.23M | 215.56M | 220.30M |
| Property Plant Equipment | 84.41M | 83.63M | 86.72M | 86.51M | 86.25M |
| Accumulated Depreciation Amortization P P E | 56.47M | 52.45M | 48.85M | 44.87M | 40.85M |
| Intangible Assets | 86.15M | 90.27M | 85.13M | 88.50M | 92.21M |
| Intangible Assets Excluding Goodwill | 34.09M | 38.21M | 33.08M | 36.44M | 39.46M |
| Goodwill | 52.06M | 52.06M | 52.06M | 52.06M | 52.75M |
| Investments | None | None | None | None | None |
| Long Term Investments | None | None | None | None | None |
| Short Term Investments | None | None | None | None | None |
| Other Current Assets | 42.72M | 43.73M | 41.49M | 40.25M | 17.78M |
| Other Non Current Assets | 360.0K | 308.0K | 254.0K | 261.0K | 155.0K |
| Total Liabilities | 201.94M | 191.41M | 156.70M | 190.26M | 192.86M |
| Total Current Liabilities | 108.89M | 86.08M | 73.92M | 93.17M | 94.12M |
| Current Accounts Payable | 2.26M | 3.76M | 5.12M | 3.95M | 4.26M |
| Deferred Revenue | 65.29M | 61.37M | 74.01M | 87.66M | 95.38M |
| Current Debt | 8.22M | 8.11M | 55.0K | 41.0K | 695.0K |
| Short Term Debt | 16.45M | 25.32M | 6.12M | 12.27M | 6.05M |
| Total Non Current Liabilities | 93.05M | 105.33M | 82.78M | 97.09M | 98.74M |
| Capital Lease Obligations | 19.50M | 21.88M | 49.85M | 0.00 | 49.66M |
| Long Term Debt | 20.51M | 22.92M | 1.13M | 1.14M | 1.82M |
| Current Long Term Debt | 74.0K | 64.0K | 55.0K | 41.0K | 695.0K |
| Long Term Debt Noncurrent | None | None | 1.13M | 1.14M | 1.82M |
| Short Long Term Debt Total | 90.62M | 89.88M | 1.13M | 1.14M | 1.82M |
| Other Current Liabilities | 40.60M | 24.79M | 26.07M | 40.52M | 39.81M |
| Other Non Current Liabilities | 3.00M | 3.00M | None | 0.00 | None |
| Total Shareholder Equity | 524.56M | 584.45M | 401.15M | 463.44M | 437.97M |
| Treasury Stock | None | None | None | None | None |
| Retained Earnings | -1.25B | -1.16B | -1.06B | -967.62M | -874.63M |
| Common Stock | 3.0K | 3.0K | 2.0K | 2.0K | 2.0K |
| Common Stock Shares Outstanding | 286.12M | 280.97M | 237.51M | 234.27M | 216.31M |
Cash Flow Statement
| 0 | 1 | 2 | 3 | 4 | |
|---|---|---|---|---|---|
| Fiscal Date Ending | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
| Reported Currency | USD | USD | USD | USD | USD |
| Operating Cashflow | -59.23M | -82.22M | -102.30M | -74.08M | -72.92M |
| Payments For Operating Activities | 4.54M | None | None | 60.0K | 11.0K |
| Proceeds From Operating Activities | None | None | None | None | None |
| Change In Operating Liabilities | 15.17M | -9.10M | -35.14M | -7.16M | -2.90M |
| Change In Operating Assets | 939.0K | -736.0K | 1.04M | 6.42M | 203.0K |
| Depreciation Depletion And Amortization | 7.20M | 8.97M | 7.38M | 7.55M | 7.58M |
| Capital Expenditures | 4.56M | 4.18M | 6.65M | 2.42M | 827.0K |
| Change In Receivables | None | None | None | None | None |
| Change In Inventory | None | None | None | -1.33M | 203.0K |
| Profit Loss | -95.84M | -97.54M | -91.37M | -93.00M | -93.02M |
| Cashflow From Investment | -4.56M | -4.18M | -6.65M | -2.49M | -347.0K |
| Cashflow From Financing | 16.46M | 263.12M | 13.90M | 80.66M | 53.77M |
| Proceeds From Repayments Of Short Term Debt | None | None | None | None | None |
| Payments For Repurchase Of Common Stock | None | None | None | None | None |
| Payments For Repurchase Of Equity | None | None | None | None | None |
| Payments For Repurchase Of Preferred Stock | None | None | None | None | None |
| Dividend Payout | None | None | None | None | None |
| Dividend Payout Common Stock | None | None | None | None | None |
| Dividend Payout Preferred Stock | None | None | None | None | None |
| Proceeds From Issuance Of Common Stock | 16.97M | 261.55M | 10.87M | 0.00 | 0.00 |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | None | None | None | None | None |
| Proceeds From Issuance Of Preferred Stock | None | None | None | None | None |
| Proceeds From Repurchase Of Equity | 18.75M | 263.15M | 13.92M | 81.35M | 53.79M |
| Proceeds From Sale Of Treasury Stock | None | None | None | None | None |
| Change In Cash And Cash Equivalents | None | None | None | None | None |
| Change In Exchange Rate | None | None | None | None | None |
| Net Income | -95.84M | -97.54M | -91.37M | -93.00M | -93.02M |
Annual Financial Statements
Ratios
| 0 | 1 | 2 | |
|---|---|---|---|
| Fiscal Date Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Reported Currency | USD | USD | USD |
| Free Cash Flow | -300.33M | -120.88M | -198.41M |
| Current Ratio | 4.70 | 5.68 | 11.46 |
| Quick Ratio | 4.74 | 5.67 | 11.43 |
| Debt to Equity Ratio | 0.41 | 0.44 | 0.12 |
| Interest Coverage Ratio | -3.4K | -4.4K | -62.17 |
| Net Profit Margin | -7.38 | -6.02 | -29.14 |
| Gross Profit Margin | -2.69 | -2.41 | -8.06 |
| Return on Assets (ROA) | -0.50 | -0.34 | -0.31 |
| Return on Equity (ROE) | -0.71 | -0.49 | -0.34 |
| COGS Ratio | 3.69 | 3.41 | 9.06 |
| Inventory Turnover | -53.10 | 106.14 | 37.36 |
| Receivables Turnover | 14.38 | 14.45 | 0.70 |
| Asset Turnover | 0.07 | 0.06 | 0.01 |
| ROIC | -1.25 | -1.58 | -0.56 |
Income Statement
| 0 | 1 | 2 | |
|---|---|---|---|
| Fiscal Date Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Reported Currency | USD | USD | USD |
| Gross Profit | -119.82M | -96.07M | -51.59M |
| Total Revenue | 44.48M | 39.79M | 6.40M |
| Cost Of Revenue | 164.30M | 135.86M | 57.99M |
| Costof Goods And Services Sold | 42.59M | 48.27M | 0.00 |
| Operating Income | -350.06M | -245.73M | -182.78M |
| Selling General And Administrative | 110.82M | 81.60M | 57.68M |
| Research And Development | 241.23M | 155.70M | 135.27M |
| Operating Expenses | 362.94M | 243.28M | 192.95M |
| Investment Income Net | None | None | None |
| Net Interest Income | -97.0K | -55.0K | -2.95M |
| Interest Income | 18.28M | 6.25M | 73.0K |
| Interest Expense | 97.0K | 55.0K | 2.95M |
| Non Interest Income | 44.58M | 39.84M | 9.35M |
| Other Non Operating Income | None | None | -3.70M |
| Depreciation | 15.90M | 11.40M | 8.80M |
| Depreciation And Amortization | 8.50M | 379.0K | 304.0K |
| Income Before Tax | -332.13M | -239.48M | -186.48M |
| Income Tax Expense | -4.06M | 0.00 | 0.00 |
| Interest And Debt Expense | 97.0K | 55.0K | 3.78M |
| Net Income From Continuing Operations | -328.07M | -239.48M | -186.48M |
| Comprehensive Income Net Of Tax | -328.07M | -239.35M | -186.60M |
| Ebit | -332.03M | -239.42M | -183.53M |
| Ebitda | -323.53M | -239.04M | -183.22M |
| Net Income | -328.07M | -239.48M | -186.48M |
Balance Sheet
| 0 | 1 | 2 | 3 | |
|---|---|---|---|---|
| Fiscal Date Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Reported Currency | USD | USD | USD | USD |
| Total Assets | 653.70M | 701.29M | 610.35M | 298.58M |
| Total Current Assets | 438.14M | 569.81M | 534.72M | 266.44M |
| Cash And Cash Equivalents At Carrying Value | 391.56M | 549.91M | 285.12M | 262.13M |
| Cash And Short Term Investments | 391.56M | 549.91M | 516.56M | 262.13M |
| Inventory | -3.09M | 1.28M | 1.55M | 5.04M |
| Current Net Receivables | 3.09M | 2.75M | 9.09M | None |
| Total Non Current Assets | 215.56M | 131.47M | 75.63M | 29.11M |
| Property Plant Equipment | 86.51M | 88.19M | 64.72M | 25.97M |
| Accumulated Depreciation Amortization P P E | 44.87M | 30.11M | 18.74M | 9.96M |
| Intangible Assets | 88.50M | 2.11M | 2.19M | 2.49M |
| Intangible Assets Excluding Goodwill | 36.44M | 1.31M | 1.39M | 1.69M |
| Goodwill | 52.06M | 801.0K | 801.0K | 801.0K |
| Investments | None | 404.61M | 399.38M | None |
| Long Term Investments | None | None | None | None |
| Short Term Investments | None | 0.00 | 231.45M | 0.00 |
| Other Current Assets | 40.25M | 15.87M | 7.51M | 2.15M |
| Other Non Current Assets | 261.0K | 0.00 | 35.0K | 650.0K |
| Total Liabilities | 190.26M | 215.48M | 67.41M | 56.56M |
| Total Current Liabilities | 93.17M | 100.27M | 46.66M | 23.10M |
| Current Accounts Payable | 3.95M | 4.59M | 2.82M | 1.07M |
| Deferred Revenue | 87.66M | 126.99M | 16.67M | None |
| Current Debt | 41.0K | 97.0K | 90.0K | None |
| Short Term Debt | 6.16M | 12.00M | 1.51M | 2.01M |
| Total Non Current Liabilities | 97.09M | 115.22M | 11.41M | 481.77M |
| Capital Lease Obligations | 0.00 | 50.37M | 10.76M | 3.17M |
| Long Term Debt | 1.14M | 633.0K | 723.0K | 11.41M |
| Current Long Term Debt | 41.0K | 97.0K | 90.0K | 1.07M |
| Long Term Debt Noncurrent | 1.14M | 633.0K | 723.0K | 12.49M |
| Short Long Term Debt Total | 1.14M | 633.0K | 723.0K | 15.66M |
| Other Current Liabilities | 46.63M | 26.95M | 32.33M | 19.74M |
| Other Non Current Liabilities | 0.00 | None | 16.01M | None |
| Total Shareholder Equity | 463.44M | 485.81M | 542.94M | -206.29M |
| Treasury Stock | None | None | None | None |
| Retained Earnings | -967.62M | -639.56M | -400.08M | -213.60M |
| Common Stock | 2.0K | 2.0K | 2.0K | 0.00 |
| Common Stock Shares Outstanding | 234.27M | 191.02M | 170.27M | 22.31M |
Cash Flow Statement
| 0 | 1 | 2 | |
|---|---|---|---|
| Fiscal Date Ending | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Reported Currency | USD | USD | USD |
| Operating Cashflow | -287.78M | -83.52M | -158.61M |
| Payments For Operating Activities | 96.0K | 55.0K | 680.0K |
| Proceeds From Operating Activities | None | None | None |
| Change In Operating Liabilities | -45.21M | 104.40M | 4.51M |
| Change In Operating Assets | 7.76M | 2.0K | 5.38M |
| Depreciation Depletion And Amortization | 24.40M | 11.76M | 8.40M |
| Capital Expenditures | 12.55M | 37.36M | 39.80M |
| Change In Receivables | None | None | -114.0K |
| Change In Inventory | None | 2.0K | 7.83M |
| Profit Loss | -328.07M | -239.48M | -186.48M |
| Cashflow From Investment | -10.23M | 193.25M | -271.74M |
| Cashflow From Financing | 140.13M | 154.34M | 458.54M |
| Proceeds From Repayments Of Short Term Debt | None | None | None |
| Payments For Repurchase Of Common Stock | None | None | None |
| Payments For Repurchase Of Equity | None | None | None |
| Payments For Repurchase Of Preferred Stock | None | None | None |
| Dividend Payout | None | None | None |
| Dividend Payout Common Stock | None | None | None |
| Dividend Payout Preferred Stock | None | None | None |
| Proceeds From Issuance Of Common Stock | 128.09M | 143.71M | 0.00 |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | None | None | None |
| Proceeds From Issuance Of Preferred Stock | None | None | None |
| Proceeds From Repurchase Of Equity | 140.90M | 154.44M | 471.34M |
| Proceeds From Sale Of Treasury Stock | None | None | None |
| Change In Cash And Cash Equivalents | None | None | 28.18M |
| Change In Exchange Rate | None | None | None |
| Net Income | -328.07M | -239.48M | -186.48M |
Legal Disclaimer
The information contained on this website and associated documents, including all text, data, analyses, opinions, and forward-looking statements, is provided solely for general informational purposes and does not constitute financial, investment, legal, or tax advice. The content has been generated by an artificial intelligence tool using publicly available data and company filings. Although every effort has been made to ensure accuracy, the information is provided “as is” without any warranty—express or implied—of completeness, accuracy, reliability, or suitability for any purpose.
Not Regulated Advice
No FCA Authorization: We are not authorized or regulated by the Financial Conduct Authority (FCA) or any other financial regulatory body to offer investment advice or recommendations. Nothing in this report should be construed as a solicitation, recommendation, or endorsement to buy, sell, or hold any security or financial instrument.
Independent Decision-Making: Investors are strongly encouraged to conduct their own research and consult with a licensed financial advisor or other professional before making any financial decisions. Reliance on the information provided herein is solely at your own risk.
Forward-Looking Statements
This report may contain forward-looking statements, which are based on current expectations, assumptions, and projections that involve risks and uncertainties. Actual results may differ materially from those expressed or implied by these statements. We do not undertake any obligation to update or revise any forward-looking statements in light of new information or future developments.
Limitation of Liability
Under no circumstances shall Aipha.io or its affiliates, employees, or agents be liable for any direct, indirect, incidental, consequential, or other damages arising out of or in connection with the use of, or reliance on, the information contained in this report—even if advised of the possibility of such damages. This includes, without limitation, any loss of profit, revenue, or data.
Use at Your Own Risk
By using this report, you acknowledge that you have read and understood this disclaimer and agree that any reliance on the information provided is at your own risk. [Your Company Name/Aipha.io] expressly disclaims any and all liability for any loss or damage of any kind incurred as a result of any use of this report.